시장보고서
상품코드
1937598

복약 준수 모니터링 시스템 시장(2026-2030년)

Global Medication Adherence Monitoring Systems Market 2026-2030

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 308 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 복약 준수 모니터링 시스템 시장은 2025년부터 2030년까지 14억 5,850만 달러 증가하고, 예측 기간 동안 CAGR은 14.9%로 예측됩니다.

세계의 복약 준수 모니터링 시스템 시장에 대해 조사분석했으며, 시장 규모와 예측, 동향, 성장요인, 과제, 약 25개 벤더 분석 등의 정보를 전해드립니다.

본 보고서는 현재 시장 상황, 최신 동향 및 촉진요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 만성질환 유병률 증가와 고령 인구 증가, 기술 발전과 의료용 사물인터넷(IoMT)의 통합, 가치 기반 의료로의 전환, 비용 억제 전략에 의해 시장이 주도되고 있습니다.

본 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보를 객관적으로 조합하여 실시되었습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.

시장 범위
기준 연도 2026년
종료 연도 2030년
예측 기간 2026-2030년
성장 모멘텀 가속
전년비 2026년 14.1%
CAGR 14.9%
증가액 14억 5,850만 달러

본 조사에서는 향후 몇 년간 세계 복약 준수 모니터링 시스템 시장의 성장을 견인할 주요 요인 중 하나로 AI 및 예측 행동 분석 기술의 보급을 꼽았습니다. 또한, 분산형 임상시험의 모니터링 시스템 도입 확대와 스마트 포장 및 생체인식 구강 센서의 발전은 시장에서 상당한 수요를 창출할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 유형별

제9장 시장 세분화 : 용도별

제10장 시장 세분화 : 최종사용자별

제11장 고객 상황

제12장 지역별 상황

제13장 촉진요인, 과제, 기회

제14장 경쟁 구도

제15장 경쟁 분석

제16장 부록

KSM 26.03.06

The global medication adherence monitoring systems market is forecasted to grow by USD 1458.5 mn during 2025-2030, accelerating at a CAGR of 14.9% during the forecast period. The report on the global medication adherence monitoring systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases and growing geriatric population, technological advancements and integration of internet of medical things, shift toward value-based care and cost containment strategies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2026
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 202614.1%
CAGR14.9%
Incremental Value$1458.5 mn

Technavio's global medication adherence monitoring systems market is segmented as below:

By Type

  • Software centric
  • Hardware centric

By Application

  • Cardiovascular
  • Diabetes
  • Oncology
  • Central nervous system
  • Others

By End-User

  • Hospitals and health systems
  • Home care settings
  • Retail pharmacies
  • Others

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • The Netherlands
    • Spain
    • Russia
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the proliferation of AI and predictive behavioral analytics as one of the prime reasons driving the global medication adherence monitoring systems market growth during the next few years. Also, increasing adoption of monitoring systems in decentralized clinical trials and evolution of smart packaging and biometric ingestible sensors will lead to sizable demand in the market.

The report on the global medication adherence monitoring systems market covers the following areas:

  • Global medication adherence monitoring systems market sizing
  • Global medication adherence monitoring systems market forecast
  • Global medication adherence monitoring systems market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global medication adherence monitoring systems market vendors that include AARDEX Group S.A., AbbVie Inc., AdhereHealth LLC, AiCure, Cardinal Health Inc., DrFirst Inc, EveryDose Inc., Hero Health Inc., Information Mediary Corp., Johnson and Johnson Services, Koninklijke Philips N.V., McKesson Corp., Medisafe, Medminder Systems Inc., Medtronic Plc, Omnicell Inc., Otsuka Holdings Co. Ltd., PillPack LLC, ResMed Inc., Vaica Medical Ltd. Also, the global medication adherence monitoring systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Medication Adherence Monitoring Systems Market 2020 - 2024
    • Historic Market Size - Data Table on Global Medication Adherence Monitoring Systems Market 2020 - 2024 ($ million)
  • 5.2 Type segment analysis 2020 - 2024
    • Historic Market Size - Type Segment 2020 - 2024 ($ million)
  • 5.3 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.4 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on Global Medication Adherence Monitoring Systems Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Type

  • 8.1 Market segments
  • 8.2 Comparison by Type
  • 8.3 Software centric - Market size and forecast 2025-2030
  • 8.4 Hardware centric - Market size and forecast 2025-2030
  • 8.5 Market opportunity by Type
    • Market opportunity by Type ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
  • 9.2 Comparison by Application
  • 9.3 Cardiovascular - Market size and forecast 2025-2030
  • 9.4 Diabetes - Market size and forecast 2025-2030
  • 9.5 Oncology - Market size and forecast 2025-2030
  • 9.6 Central nervous system - Market size and forecast 2025-2030
  • 9.7 Others - Market size and forecast 2025-2030
  • 9.8 Market opportunity by Application
    • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
  • 10.2 Comparison by End-user
  • 10.3 Hospitals and health systems - Market size and forecast 2025-2030
  • 10.4 Home care settings - Market size and forecast 2025-2030
  • 10.5 Retail pharmacies - Market size and forecast 2025-2030
  • 10.6 Others - Market size and forecast 2025-2030
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 The Netherlands - Market size and forecast 2025-2030
    • 12.4.6 Spain - Market size and forecast 2025-2030
    • 12.4.7 Russia - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 Japan - Market size and forecast 2025-2030
    • 12.5.3 India - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Indonesia - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
    • 12.5.7 Singapore - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Australia - Market size and forecast 2025-2030
    • 12.6.2 UAE - Market size and forecast 2025-2030
    • 12.6.3 Brazil - Market size and forecast 2025-2030
    • 12.6.4 South Africa - Market size and forecast 2025-2030
    • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.6 Turkey - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Rising prevalence of chronic diseases and growing geriatric population
    • Technological advancements and integration of internet of medical things
    • Shift toward value-based care and cost containment strategies
  • 13.2 Market challenges
    • Concerns regarding data privacy and cybersecurity vulnerabilities
    • Integration complexity and lack of interoperability with healthcare infrastructure
    • High implementation costs and inconsistent reimbursement frameworks
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Proliferation of AI and predictive behavioral analytics
    • Increasing adoption of monitoring systems in decentralized clinical trials
    • Evolution of smart packaging and biometric ingestible sensors

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AARDEX Group S.A.
    • AARDEX Group S.A. - Overview
    • AARDEX Group S.A. - Product / Service
    • AARDEX Group S.A. - Key offerings
    • SWOT
  • 15.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Business segments
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • AbbVie Inc. - Segment focus
    • SWOT
  • 15.6 AdhereHealth LLC
    • AdhereHealth LLC - Overview
    • AdhereHealth LLC - Product / Service
    • AdhereHealth LLC - Key offerings
    • SWOT
  • 15.7 AiCure
    • AiCure - Overview
    • AiCure - Product / Service
    • AiCure - Key offerings
    • SWOT
  • 15.8 Cardinal Health Inc.
    • Cardinal Health Inc. - Overview
    • Cardinal Health Inc. - Business segments
    • Cardinal Health Inc. - Key news
    • Cardinal Health Inc. - Key offerings
    • Cardinal Health Inc. - Segment focus
    • SWOT
  • 15.9 DrFirst Inc
    • DrFirst Inc - Overview
    • DrFirst Inc - Product / Service
    • DrFirst Inc - Key offerings
    • SWOT
  • 15.10 EveryDose Inc.
    • EveryDose Inc. - Overview
    • EveryDose Inc. - Product / Service
    • EveryDose Inc. - Key offerings
    • SWOT
  • 15.11 Hero Health Inc.
    • Hero Health Inc. - Overview
    • Hero Health Inc. - Product / Service
    • Hero Health Inc. - Key offerings
    • SWOT
  • 15.12 Information Mediary Corp.
    • Information Mediary Corp. - Overview
    • Information Mediary Corp. - Product / Service
    • Information Mediary Corp. - Key offerings
    • SWOT
  • 15.13 Johnson and Johnson Services
    • Johnson and Johnson Services - Overview
    • Johnson and Johnson Services - Business segments
    • Johnson and Johnson Services - Key news
    • Johnson and Johnson Services - Key offerings
    • Johnson and Johnson Services - Segment focus
    • SWOT
  • 15.14 Koninklijke Philips N.V.
    • Koninklijke Philips N.V. - Overview
    • Koninklijke Philips N.V. - Business segments
    • Koninklijke Philips N.V. - Key news
    • Koninklijke Philips N.V. - Key offerings
    • Koninklijke Philips N.V. - Segment focus
    • SWOT
  • 15.15 McKesson Corp.
    • McKesson Corp. - Overview
    • McKesson Corp. - Business segments
    • McKesson Corp. - Key news
    • McKesson Corp. - Key offerings
    • McKesson Corp. - Segment focus
    • SWOT
  • 15.16 Medisafe
    • Medisafe - Overview
    • Medisafe - Product / Service
    • Medisafe - Key offerings
    • SWOT
  • 15.17 Medminder Systems Inc.
    • Medminder Systems Inc. - Overview
    • Medminder Systems Inc. - Product / Service
    • Medminder Systems Inc. - Key offerings
    • SWOT
  • 15.18 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제